NUCLEUS 22 CI22M NA

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor report with the FDA on 2020-03-26 for NUCLEUS 22 CI22M NA manufactured by Cochlear Ltd.

Event Text Entries

[186523763] This report is submitted on 27 march 2020.
Patient Sequence No: 1, Text Type: N, H10


[186523764] It was reported that due to a decrease in performance the device was explanted on (b)(6) 2019. The patient was re-implanted with a new device during the same surgery.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number6000034-2020-00873
MDR Report Key9887136
Report SourceDISTRIBUTOR
Date Received2020-03-26
Date of Report2020-03-05
Date of Event2019-11-21
Date Mfgr Received2020-03-05
Date Added to Maude2020-03-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. KRISTEL KOHNE
Manufacturer Street1 UNIVERSITY AVENUE
Manufacturer CityMACQUARIE UNIVERSITY, NSW 2109,
Manufacturer CountryAS
Manufacturer Postal2109,
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNUCLEUS 22
Generic NameNUCLEUS 22 COCHLEAR IMPLANT SYSTEM
Product CodeMCM
Date Received2020-03-26
Model NumberCI22M
Catalog NumberNA
Lot NumberNA
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCOCHLEAR LTD
Manufacturer Address1 UNIVERSITY AVENUE MACQUARIE UNIVERSITY, NSW 2109 AS 2109


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.